Symbols / NTHI Stock $4.79 -4.20% NeOnc Technologies Holdings, Inc.
NTHI (Stock) Chart
About
NeOnc Technologies Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on developing treatments for intracranial malignancies. Its lead product candidates include NEO100, a purified form of preillyl acid that is in Phase IIa clinical trial; and NEO212, a covalently conjugated molecule combining chemotherapeutic drug temozolomide with perillyl alcohol that is in Phase I/II clinical trials for its oral administration for the treatment of primary brain cancers, such as meningioma, high grade gliomas, glioblastoma, and secondary brain cancers. The company was formerly known as NAS-ONC, Inc. and changed its name to NeOnc Technologies Holdings, Inc. in 2009. The company was incorporated in 2005 and is headquartered in Calabasas, California.
Stock Fundamentals
Scroll to Statements| Market Cap | 117.88M | Enterprise Value | 124.10M | Income | -62.15M | Sales | 39.99K | Book/sh | -0.80 | Cash/sh | 0.00 |
| Dividend Yield | — | Payout | 0.00% | Employees | 5 | IPO | — | P/E | — | Forward P/E | -3.24 |
| PEG | — | P/S | 2947.63 | P/B | -6.02 | P/C | — | EV/EBITDA | — | EV/Sales | 3103.17 |
| Quick Ratio | 0.01 | Current Ratio | 0.07 | Debt/Eq | — | LT Debt/Eq | — | EPS (ttm) | -3.20 | EPS next Y | -1.48 |
| EPS Growth | — | Revenue Growth | -100.00% | Earnings | 2026-05-15 | ROA | -11.67% | ROE | — | ROIC | — |
| Gross Margin | 100.00% | Oper. Margin | -1456.38% | Profit Margin | 0.00% | Shs Outstand | 24.61M | Shs Float | 9.43M | Short Float | 2.09% |
| Short Ratio | 7.89 | Short Interest | — | 52W High | 12.99 | 52W Low | 3.20 | Beta | — | Avg Volume | 50.47K |
| Volume | 68.76K | Target Price | — | Recom | None | Prev Close | $5.00 | Price | $4.79 | Change | -4.20% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
- [EFFECT] NEONC TECHNOLOGIES HOLDINGS, INC. SEC Filing | NTHI SEC Filing - Form EFFECT - Stock Titan hu, 09 Apr 2026 07
- NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results - ChartMill ue, 14 Apr 2026 13
- NeonC technologies (NTHI) president buys $153k in stock - Investing.com Mon, 06 Apr 2026 07
- NeOnc Technologies Holdings, Inc. Announces ~ $300,000 in Insider Purchases of NTHI Stock by Chairman and CEO; Company Provides Context on 2025 Financial Results - The Globe and Mail ue, 14 Apr 2026 13
- What is driving NeOnc (NTHI) stock | Q4 2025: Below Expectations - Verified Analyst Reports - Cổng thông tin điện tử tỉnh Lào Cai Wed, 22 Apr 2026 22
- Brain cancer drug data in 5 months as NeOnc posts $62.1M Q4 loss - Stock Titan Wed, 01 Apr 2026 07
- NeonC Technologies (NTHI) president buys $48,949 in stock - Investing.com Fri, 10 Apr 2026 07
- NeOnc Technologies (NTHI) sets up $75M at-the-market share sale - Stock Titan Fri, 10 Apr 2026 07
- NeOnc chief buys $300K in shares as FDA meeting nears in 4 weeks - Stock Titan ue, 14 Apr 2026 13
- CEO’s $300K NTHI buy and 2025 loss breakdown at NeOnc (NTHI) - Stock Titan hu, 16 Apr 2026 21
- NEONC Technologies (NTHI) officer buys stock and receives 170,000-share grant - Stock Titan Mon, 13 Apr 2026 07
- Resale filing: NeOnc (NASDAQ: NTHI) registers 680,558 shares including warrants - Stock Titan hu, 16 Apr 2026 20
- Insider Amir Heshmatpour adds 10,000 Neonc (NTHI) shares to stake - Stock Titan Fri, 10 Apr 2026 07
- NEONC Technologies (NTHI) president and 10% owner adds 15,000 shares in open-market buys - Stock Titan hu, 09 Apr 2026 07
- What is driving NeOnc (NTHI) stock | Q4 2025: Below Expectations - Stock Community Signals - Cổng thông tin điện tử tỉnh Lào Cai hu, 23 Apr 2026 03
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.04
-51.82%
|
0.08
+17.79%
|
0.07
+252.31%
|
0.02
|
| Operating Revenue |
|
0.04
-51.82%
|
0.08
+17.79%
|
0.07
+252.31%
|
0.02
|
| Operating Expense |
|
58.21
+705.61%
|
7.23
-11.54%
|
8.17
+185.84%
|
2.86
|
| Research And Development |
|
3.64
+19.47%
|
3.05
+98.50%
|
1.53
+31.87%
|
1.16
|
| Selling General And Administration |
|
42.85
+1064.43%
|
3.68
+8.36%
|
3.40
+100.45%
|
1.69
|
| General And Administrative Expense |
|
42.85
+1064.43%
|
3.68
+8.36%
|
3.40
+100.45%
|
1.69
|
| Salaries And Wages |
|
35.56
|
0.00
|
—
|
—
|
| Other Gand A |
|
7.30
+98.34%
|
3.68
+8.36%
|
3.40
+100.45%
|
1.69
|
| Other Operating Expenses |
|
11.72
+2243.31%
|
0.50
-84.56%
|
3.24
|
—
|
| Total Expenses |
|
58.21
+705.61%
|
7.23
-11.54%
|
8.17
+185.84%
|
2.86
|
| Operating Income |
|
-58.17
-714.41%
|
-7.14
+11.80%
|
-8.10
-185.37%
|
-2.84
|
| Total Operating Income As Reported |
|
-58.24
-715.40%
|
-7.14
+41.44%
|
-12.20
-329.86%
|
-2.84
|
| EBITDA |
|
-59.61
-555.33%
|
-9.10
+25.43%
|
-12.20
-328.50%
|
-2.85
|
| Normalized EBITDA |
|
-58.92
-738.59%
|
-7.03
+13.24%
|
-8.10
-184.47%
|
-2.85
|
| Reconciled Depreciation |
|
0.04
-85.18%
|
0.25
|
0.00
|
—
|
| EBIT |
|
-59.64
-538.47%
|
-9.34
+23.42%
|
-12.20
-328.50%
|
-2.85
|
| Total Unusual Items |
|
-0.69
+66.69%
|
-2.07
+49.51%
|
-4.10
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
-0.69
+66.69%
|
-2.07
+49.51%
|
-4.10
|
0.00
|
| Special Income Charges |
|
0.00
+100.00%
|
-2.07
+49.51%
|
-4.10
|
0.00
|
| Other Special Charges |
|
—
|
2.07
-49.51%
|
4.10
|
—
|
| Net Income |
|
-62.15
-422.30%
|
-11.90
+20.26%
|
-14.92
-389.74%
|
-3.05
|
| Pretax Income |
|
-62.15
-422.30%
|
-11.90
+20.26%
|
-14.92
-389.74%
|
-3.05
|
| Net Non Operating Interest Income Expense |
|
-3.29
-22.39%
|
-2.69
+1.37%
|
-2.72
-1260.66%
|
-0.20
|
| Interest Expense Non Operating |
|
2.50
-2.05%
|
2.56
-6.11%
|
2.72
+1260.66%
|
0.20
|
| Net Interest Income |
|
-3.29
-22.39%
|
-2.69
+1.37%
|
-2.72
-1260.66%
|
-0.20
|
| Interest Expense |
|
2.50
-2.05%
|
2.56
-6.11%
|
2.72
+1260.66%
|
0.20
|
| Interest Income Non Operating |
|
0.33
+1930.51%
|
0.02
|
0.00
|
—
|
| Interest Income |
|
0.33
+1930.51%
|
0.02
|
0.00
|
—
|
| Other Income Expense |
|
-0.69
+66.69%
|
-2.07
+49.51%
|
-4.10
-45455.56%
|
-0.01
|
| Other Non Operating Income Expenses |
|
—
|
—
|
—
|
-0.01
|
| Gain On Sale Of Security |
|
-0.69
|
—
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-62.15
-422.30%
|
-11.90
+20.26%
|
-14.92
-389.74%
|
-3.05
|
| Net Income From Continuing Operation Net Minority Interest |
|
-62.15
-422.30%
|
-11.90
+20.26%
|
-14.92
-389.74%
|
-3.05
|
| Net Income From Continuing And Discontinued Operation |
|
-62.15
-422.30%
|
-11.90
+20.26%
|
-14.92
-389.74%
|
-3.05
|
| Net Income Continuous Operations |
|
-62.15
-422.30%
|
-11.90
+20.26%
|
-14.92
-389.74%
|
-3.05
|
| Normalized Income |
|
-61.46
-525.29%
|
-9.83
+9.17%
|
-10.82
-255.17%
|
-3.05
|
| Net Income Common Stockholders |
|
-62.15
-422.30%
|
-11.90
+20.26%
|
-14.92
-389.74%
|
-3.05
|
| Diluted EPS |
|
—
|
-0.63
+20.26%
|
-0.80
-389.73%
|
-0.16
|
| Basic EPS |
|
—
|
-0.63
+20.26%
|
-0.80
-389.73%
|
-0.16
|
| Basic Average Shares |
|
—
|
18.75
+0.00%
|
18.75
+0.00%
|
18.75
|
| Diluted Average Shares |
|
—
|
18.75
+0.00%
|
18.75
+0.00%
|
18.75
|
| Diluted NI Availto Com Stockholders |
|
-62.15
-422.30%
|
-11.90
+20.26%
|
-14.92
-389.74%
|
-3.05
|
| Total Other Finance Cost |
|
1.11
+665.34%
|
0.15
|
—
|
—
|
| Line Item | Trend | 2025-12-31 |
|---|---|---|
| Total Assets |
|
2.82
|
| Current Assets |
|
1.39
|
| Cash Cash Equivalents And Short Term Investments |
|
0.06
|
| Cash And Cash Equivalents |
|
0.06
|
| Cash Financial |
|
0.06
|
| Prepaid Assets |
|
0.58
|
| Current Deferred Assets |
|
0.08
|
| Hedging Assets Current |
|
0.67
|
| Total Non Current Assets |
|
1.43
|
| Net PPE |
|
0.36
|
| Gross PPE |
|
0.36
|
| Other Properties |
|
0.36
|
| Goodwill And Other Intangible Assets |
|
0.50
|
| Other Non Current Assets |
|
0.05
|
| Total Liabilities Net Minority Interest |
|
20.33
|
| Current Liabilities |
|
20.04
|
| Payables And Accrued Expenses |
|
13.76
|
| Payables |
|
12.01
|
| Accounts Payable |
|
7.11
|
| Other Payable |
|
4.89
|
| Current Accrued Expenses |
|
1.76
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.26
|
| Current Debt And Capital Lease Obligation |
|
6.02
|
| Current Debt |
|
5.95
|
| Other Current Borrowings |
|
5.95
|
| Current Capital Lease Obligation |
|
0.07
|
| Current Deferred Liabilities |
|
—
|
| Current Deferred Revenue |
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.29
|
| Long Term Debt And Capital Lease Obligation |
|
0.29
|
| Long Term Capital Lease Obligation |
|
0.29
|
| Stockholders Equity |
|
-17.51
|
| Common Stock Equity |
|
-17.51
|
| Capital Stock |
|
0.00
|
| Common Stock |
|
0.00
|
| Preferred Stock |
|
0.00
|
| Share Issued |
|
21.99
|
| Ordinary Shares Number |
|
21.69
|
| Treasury Shares Number |
|
0.30
|
| Additional Paid In Capital |
|
97.95
|
| Retained Earnings |
|
-112.75
|
| Treasury Stock |
|
2.71
|
| Total Equity Gross Minority Interest |
|
-17.51
|
| Total Capitalization |
|
-17.51
|
| Working Capital |
|
-18.65
|
| Invested Capital |
|
-11.56
|
| Total Debt |
|
6.31
|
| Net Debt |
|
5.89
|
| Capital Lease Obligations |
|
0.36
|
| Net Tangible Assets |
|
-18.01
|
| Tangible Book Value |
|
-18.01
|
| Current Notes Payable |
|
—
|
| Dueto Related Parties Current |
|
—
|
| Financial Assets |
|
0.53
|
| Preferred Stock Equity |
|
—
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-20.36
-383.25%
|
-4.21
-124.14%
|
-1.88
-113.22%
|
-0.88
|
| Cash Flow From Continuing Operating Activities |
|
-20.36
-383.25%
|
-4.21
-124.14%
|
-1.88
-113.22%
|
-0.88
|
| Net Income From Continuing Operations |
|
-62.15
-422.30%
|
-11.90
+20.26%
|
-14.92
-389.74%
|
-3.05
|
| Depreciation Amortization Depletion |
|
0.04
-85.18%
|
0.25
|
0.00
|
—
|
| Depreciation |
|
0.04
-85.18%
|
0.25
|
0.00
|
—
|
| Depreciation And Amortization |
|
0.04
-85.18%
|
0.25
|
0.00
|
—
|
| Other Non Cash Items |
|
3.36
+5.79%
|
3.18
-71.94%
|
11.33
+5375.01%
|
0.21
|
| Stock Based Compensation |
|
35.56
|
0.00
|
0.00
-100.00%
|
1.29
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
0.70
|
0.00
|
—
|
| Operating Gains Losses |
|
0.69
-66.69%
|
2.07
|
—
|
—
|
| Gain Loss On Investment Securities |
|
0.69
|
—
|
—
|
—
|
| Change In Working Capital |
|
2.14
+43.89%
|
1.49
-13.27%
|
1.71
+157.24%
|
0.67
|
| Change In Receivables |
|
—
|
—
|
—
|
0.00
|
| Changes In Account Receivables |
|
—
|
—
|
—
|
0.00
|
| Change In Prepaid Assets |
|
-0.20
-58.97%
|
-0.12
-399.02%
|
-0.02
+71.82%
|
-0.09
|
| Change In Payables And Accrued Expense |
|
2.39
+29.10%
|
1.85
+6.68%
|
1.74
+130.53%
|
0.75
|
| Change In Accrued Expense |
|
1.28
+2175.69%
|
0.06
-91.73%
|
0.68
+1457.49%
|
-0.05
|
| Change In Payable |
|
1.12
-37.89%
|
1.80
+69.71%
|
1.06
+31.79%
|
0.80
|
| Change In Account Payable |
|
1.12
-37.89%
|
1.80
+69.71%
|
1.06
+31.79%
|
0.80
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
-0.05
|
| Change In Other Current Assets |
|
-0.05
|
0.00
|
—
|
—
|
| Change In Other Current Liabilities |
|
-0.01
+95.03%
|
-0.24
|
0.00
|
—
|
| Investing Cash Flow |
|
-0.50
|
0.00
|
—
|
—
|
| Cash Flow From Continuing Investing Activities |
|
-0.50
|
0.00
|
—
|
—
|
| Capital Expenditure |
|
-0.50
|
—
|
—
|
—
|
| Net Intangibles Purchase And Sale |
|
-0.50
|
0.00
|
—
|
—
|
| Purchase Of Intangibles |
|
-0.50
|
0.00
|
—
|
—
|
| Financing Cash Flow |
|
20.86
+391.12%
|
4.25
+232.16%
|
1.28
-14.19%
|
1.49
|
| Cash Flow From Continuing Financing Activities |
|
20.86
+391.12%
|
4.25
+232.16%
|
1.28
-14.19%
|
1.49
|
| Net Issuance Payments Of Debt |
|
3.70
+3565.14%
|
0.10
-92.65%
|
1.37
+753.66%
|
-0.21
|
| Issuance Of Debt |
|
4.30
+382.05%
|
0.89
-74.57%
|
3.51
+2706.38%
|
0.12
|
| Repayment Of Debt |
|
-0.60
+24.15%
|
-0.79
+62.95%
|
-2.14
-537.40%
|
-0.34
|
| Long Term Debt Issuance |
|
4.00
|
0.00
|
—
|
—
|
| Net Long Term Debt Issuance |
|
4.00
|
0.00
|
—
|
—
|
| Short Term Debt Issuance |
|
0.30
-66.37%
|
0.89
-74.57%
|
3.51
+2706.38%
|
0.12
|
| Short Term Debt Payments |
|
-0.60
+24.15%
|
-0.79
+62.95%
|
-2.14
-537.40%
|
-0.34
|
| Net Short Term Debt Issuance |
|
-0.30
-397.17%
|
0.10
-92.65%
|
1.37
+753.66%
|
-0.21
|
| Net Common Stock Issuance |
|
17.16
+271.72%
|
4.62
+1025630.89%
|
0.00
-99.98%
|
2.40
|
| Net Other Financing Charges |
|
—
|
-0.47
-396.77%
|
-0.09
+86.49%
|
-0.70
|
| Changes In Cash |
|
-0.01
-118.66%
|
0.03
+105.49%
|
-0.60
-198.88%
|
0.61
|
| Beginning Cash Position |
|
0.06
+103.67%
|
0.03
-94.97%
|
0.63
+2429.75%
|
0.03
|
| End Cash Position |
|
0.06
-9.50%
|
0.06
+103.67%
|
0.03
-94.97%
|
0.63
|
| Free Cash Flow |
|
-20.86
-395.12%
|
-4.21
-124.14%
|
-1.88
-113.22%
|
-0.88
|
| Interest Paid Supplemental Data |
|
—
|
—
|
0.00
-100.00%
|
0.00
|
| Common Stock Issuance |
|
17.16
+271.72%
|
4.62
+1025630.89%
|
0.00
-99.98%
|
2.40
|
| Issuance Of Capital Stock |
|
17.16
+271.72%
|
4.62
+1025630.89%
|
0.00
-99.98%
|
2.40
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-16 View
- 42026-04-13 View
- 8-K2026-04-10 View
- 42026-04-10 View
- 42026-04-09 View
- 42026-04-06 View
- 8-K2026-04-03 View
- 10-K2026-03-31 View
- 8-K2026-03-23 View
- 8-K2026-03-17 View
- 8-K2026-03-06 View
- 8-K2026-03-04 View
- 8-K2026-03-03 View
- 8-K2026-02-27 View
- 8-K2026-01-29 View
- 8-K2025-12-17 View
- 8-K2025-12-05 View
- 42025-11-24 View
- 42025-11-24 View
- 8-K2025-11-14 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|